Consistently, an elevated cytoplasmic CdGAP expression in prostate cancer cells was associated with bone metastasis in prostate cancer patients, further supporting an important role for CdGAP in prostate cancer progression. This evidence concerns the gene ARHGAP31 and Familial prostate cancer.